Power-Up: An Effectiveness Trial of the Diabetes Prevention Program
Power-Up
2 other identifiers
interventional
301
1 country
1
Brief Summary
The goal of this study is to address the risk of diabetes among men by creating a Diabetes Prevention Program (DPP) tailored to men.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable type-2-diabetes
Started Aug 2021
Typical duration for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2019
CompletedFirst Posted
Study publicly available on registry
September 26, 2019
CompletedStudy Start
First participant enrolled
August 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 7, 2025
CompletedResults Posted
Study results publicly available
March 30, 2026
CompletedMarch 30, 2026
March 1, 2026
3.5 years
September 19, 2019
February 9, 2026
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Percent Weight Change Through 16 Sessions
The percent weight change through 16 sessions was compared. Mean percent weight change for each arm for all intent-to-treat (ITT) participants (i.e.. attended \>=0 sessions), as well as those who were considered "Engaged" (i.e., attended \>=4 sessions) or "Retained" (i.e., attended \>=9 sessions), through 16 scheduled sessions, was determined. All data is crude and unadjusted with no imputation.
Up to 6 months, after the delivery of the 16th session (end of the core phase)
Percent Weight Change Through the 12 Month Trial
The percent weight change through 12 months was compared. Mean percent weight change for each arm for all intent-to-treat (ITT) participants (i.e., attended \>=0 sessions), as well as those who were considered "Engaged" (i.e., attended \>=4 sessions) or "Retained" (i.e., attended \>=9 sessions), through 12 months, was determined. All data is crude and unadjusted with no imputation.
12 Months (At end of maintenance phase)
Secondary Outcomes (2)
Engagement of Men in Power-Up vs Standard National Diabetes Prevention Program
6 Months (At end of the core phase)
Retention of Men in Power-Up vs Standard National Diabetes Prevention Program
12 Months (At end of the maintenance phase)
Study Arms (2)
Power-Up
EXPERIMENTALParticipants randomized to this arm will undergo 16 classes tailored for men, that discuss food choices, physical activity, and managing stress over 6 months, which are called the core, and 6 classes over the following 6 months, which is called the maintenance phase.
Standard NDPP (National Diabetes Prevention Program)
NO INTERVENTIONParticipants randomized to this arm will undergo 16 mixed gender classes that discuss food choices, physical activity, and managing stress over 6 months which are called the core and 6 classes over the following 6 months which is called the maintenance phase.
Interventions
Evaluating whether a diabetes prevention program (DPP) tailored for men (Power-Up) will show better or similar percent weight loss and retention than a standard mixed-gender DPP
Eligibility Criteria
You may qualify if:
- At least 18 years old
- Most recent HbA1c: 5.7%-6.4% (within last year) or Diabetes Risk Score \>= 5
- Most recent BMI ≥ 25 (within last 6 months)
- Access to a device that can join sessions virtually either through a virtual conferencing application
- Have valid address and telephone contact information
- Have no plans to change their health system/primary care provider or move from their current, NYC area, address in the next year
You may not qualify if:
- Not physically able or willing to attend virtual, group-based sessions
- Unable to provide informed consent by telephone
- Unable or unwilling to complete baseline telephone surveys or follow-up surveys in English or Spanish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
Related Publications (4)
Walker EA, Weiss L, Gary-Webb TL, Realmuto L, Kamler A, Ravenell J, Tejeda C, Lukin J, Schechter CB. Power Up for Health: Pilot Study Outcomes of a Diabetes Prevention Program for Men from Disadvantaged Neighborhoods. Am J Mens Health. 2018 Jul;12(4):989-997. doi: 10.1177/1557988318758787. Epub 2018 Mar 15.
PMID: 29540129BACKGROUNDRealmuto L, Kamler A, Weiss L, Gary-Webb TL, Hodge ME, Pagan JA, Walker EA. Power Up for Health-Participants' Perspectives on an Adaptation of the National Diabetes Prevention Program to Engage Men. Am J Mens Health. 2018 Jul;12(4):981-988. doi: 10.1177/1557988318758786. Epub 2018 Mar 15.
PMID: 29540130BACKGROUNDGary-Webb TL, Walker EA, Realmuto L, Kamler A, Lukin J, Tyson W, Carrasquillo O, Weiss L. Translation of the National Diabetes Prevention Program to Engage Men in Disadvantaged Neighborhoods in New York City: A Description of Power Up for Health. Am J Mens Health. 2018 Jul;12(4):998-1006. doi: 10.1177/1557988318758788. Epub 2018 Mar 15.
PMID: 29540131BACKGROUNDChambers EC, Walker EA, Schechter C, Gil E, Herbert T, Diaz K, Gonzalez J. Virtual Diabetes Prevention Program Tailored to Increase Participation of Black and Latino Men: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 Jun 24;14:e64405. doi: 10.2196/64405.
PMID: 40554781RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Earle C. Chambers, PhD, MPH
- Organization
- Albert Einstein College of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Earle Chambers, PhD
Albert Einstein College of Medicine
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2019
First Posted
September 26, 2019
Study Start
August 9, 2021
Primary Completion
February 7, 2025
Study Completion
February 7, 2025
Last Updated
March 30, 2026
Results First Posted
March 30, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share